Skip to Content

THC Biomed International Ltd THCBF

Morningstar Rating
$0.01 0.00 (9.17%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

THCBF is trading at a 58% discount.
Price
$0.01
Fair Value
$3.86
Uncertainty
Extreme
1-Star Price
$9.68
5-Star Price
$9.28
Economic Moat
Rkwpp
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if THCBF is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.01
Day Range
$0.010.01
52-Week Range
$0.010.05
Bid/Ask
$0.01 / $0.02
Market Cap
$1.72 Mil
Volume/Avg
50,963 / 22,213

Key Statistics

Price/Earnings (Normalized)
Price/Sales
0.80
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

THC Biomed International Ltd operates as a licensed producer under Canada's Marijuana for Medical Purposes Regulations (MMPR). It is also engaged in the research and development of the products and services to medical marihuana. In addition, it is also engaged in providing horticulture training, record keeping and documenting research studies, and analytical services. Geographically all the activities are carried out through the region of Canada.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Value
Total Number of Employees
35

Valuation

Metric
THCBF
Price/Earnings (Normalized)
Price/Book Value
0.52
Price/Sales
0.80
Price/Cash Flow
Price/Earnings
THCBF

Financial Strength

Metric
THCBF
Quick Ratio
0.04
Current Ratio
0.41
Interest Coverage
−4.85
Quick Ratio
THCBF

Profitability

Metric
THCBF
Return on Assets (Normalized)
−25.96%
Return on Equity (Normalized)
−59.04%
Return on Invested Capital (Normalized)
−28.59%
Return on Assets
THCBF
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
ZTS
Zoetis Inc Class AVpj$87.4 Bil
MKKGY
Merck KGaA ADRBlrlk$74.3 Bil
HLN
Haleon PLC ADRRzbq$38.5 Bil
VTRS
Viatris IncJmzy$15.1 Bil
RDY
Dr Reddy's Laboratories Ltd ADRGswd$12.4 Bil
CTLT
Catalent IncHyjpxn$10.3 Bil
CURLF
Curaleaf Holdings IncFmz$3.6 Bil
PRGO
Perrigo Co PLCTsb$3.6 Bil
PBH
Prestige Consumer Healthcare IncTzwtf$3.5 Bil
GTBIF
Green Thumb Industries IncCdcp$3.1 Bil

Sponsor Center